These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 9462843

  • 1. Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).
    Paik SR, Lee JH, Kim DH, Chang CS, Kim YS.
    FEBS Lett; 1998 Jan 02; 421(1):73-6. PubMed ID: 9462843
    [Abstract] [Full Text] [Related]

  • 2. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.
    Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T.
    Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9141-5. PubMed ID: 7568089
    [Abstract] [Full Text] [Related]

  • 3. Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid.
    Paik SR, Lee JH, Kim DH, Chang CS, Kim J.
    Arch Biochem Biophys; 1997 Aug 15; 344(2):325-34. PubMed ID: 9264546
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of the NACP self-oligomerizations induced by Abeta25-35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline.
    Lee JH, Shin HJ, Chang CS, Paik SR.
    Neurochem Res; 1998 Nov 15; 23(11):1427-34. PubMed ID: 9814554
    [Abstract] [Full Text] [Related]

  • 5. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.
    Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT.
    Biochemistry; 1996 Oct 29; 35(43):13709-15. PubMed ID: 8901511
    [Abstract] [Full Text] [Related]

  • 6. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR, Shin HJ, Lee JH, Chang CS, Kim J.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
    Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11282-6. PubMed ID: 8248242
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
    Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E.
    Neuroreport; 1999 Mar 17; 10(4):717-21. PubMed ID: 10208537
    [Abstract] [Full Text] [Related]

  • 9. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
    Masliah E, Iwai A, Mallory M, Uéda K, Saitoh T.
    Am J Pathol; 1996 Jan 17; 148(1):201-10. PubMed ID: 8546207
    [Abstract] [Full Text] [Related]

  • 10. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?
    Han H, Weinreb PH, Lansbury PT.
    Chem Biol; 1995 Mar 17; 2(3):163-9. PubMed ID: 9383418
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system.
    Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1996 Aug 17; 55(8):889-95. PubMed ID: 8759778
    [Abstract] [Full Text] [Related]

  • 12. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR, Shin HJ, Lee JH.
    Arch Biochem Biophys; 2000 Jun 15; 378(2):269-77. PubMed ID: 10860544
    [Abstract] [Full Text] [Related]

  • 13. Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil.
    Kim J.
    Mol Cells; 1997 Feb 28; 7(1):78-83. PubMed ID: 9085269
    [Abstract] [Full Text] [Related]

  • 14. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A.
    Biochim Biophys Acta; 2000 Jul 26; 1502(1):95-109. PubMed ID: 10899435
    [Abstract] [Full Text] [Related]

  • 15. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development.
    Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E.
    J Neurochem; 1998 Jul 26; 71(1):338-44. PubMed ID: 9648883
    [Abstract] [Full Text] [Related]

  • 16. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.
    Jensen PH, Sørensen ES, Petersen TE, Gliemann J, Rasmussen LK.
    Biochem J; 1995 Aug 15; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476
    [Abstract] [Full Text] [Related]

  • 17. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.
    Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thal LJ, Saitoh T.
    Ann Neurol; 1996 Aug 15; 40(2):207-15. PubMed ID: 8773602
    [Abstract] [Full Text] [Related]

  • 18. Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus.
    Ishimaru H, Uéda K, Takahashi A, Maruyama Y.
    Brain Res; 1998 Mar 30; 788(1-2):311-4. PubMed ID: 9555070
    [Abstract] [Full Text] [Related]

  • 19. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jäkälä P, Hartmann T, Beyreuther K, Masters CL, Li QX.
    Am J Pathol; 1999 Oct 30; 155(4):1173-81. PubMed ID: 10514400
    [Abstract] [Full Text] [Related]

  • 20. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
    Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E.
    Lab Invest; 1998 Sep 30; 78(9):1169-77. PubMed ID: 9759660
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.